Company Performance: Positive earnings reports, successful clinical trials, and strong pipeline progress typically drive the stock price up. Conversely, disappointing results or regulatory setbacks can cause it to decline. Industry Trends: Developments in the broader healthcare sector, particularly in oncology and immunotherapy, influence investor sentiment towards SELLAS Life Sciences. Positive trends can create tailwinds, while negative ones can create headwinds. Market Conditions: Overall market sentiment and economic conditions affect all stocks. A bullish market usually supports higher stock prices, while a bearish market can depress them. Regulatory Approvals: Regulatory decisions by health authorities like the FDA significantly impact the perceived value of SELLAS Life Sciences' products and, therefore, the stock price. Approval news generally causes jumps. Competition: Competitor activity, including new drug launches or trial results, can affect SELLAS Life Sciences' market position and investor confidence, influencing the stock. Financial Health: The company's cash position, debt levels, and ability to fund research and development are crucial factors. A strong financial footing provides stability and attracts investors. News and Events: Major announcements, such as partnerships, acquisitions, or key presentations at scientific conferences, can create short-term price volatility and influence the overall trend. Analyst Ratings: Investment bank analysts publish ratings and price targets, which can influence investor perceptions of SELLAS Life Sciences and impact buying or selling pressure on the stock.